Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment of Obsessive-Compulsive Disorder
This study has been completed.
Study NCT00000373   Information provided by National Institute of Mental Health (NIMH)
First Received: November 2, 1999   Last Updated: December 6, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Obsessive-Compulsive Disorder
Additional conditions recognized in this trial
Disease
More general conditions related to this trial
Anxiety Disorders
Mental Disorders
Pathologic Processes
Interventions listed in this trial
Fluoxetine
Olanzapine
Additional drug interventions recognized in this trial
Antipsychotic Agents
Serotonin Uptake Inhibitors
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antiemetics
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
National Institute of Mental Health (NIMH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services